Basilea reports activity of derazantinib in preclinical models of gastric cancer at ASCO Gastrointestinal Cancers Symposium

    NEXT STORY
    Marketing authorization granted for darolutamide in Japan
    PREV STORY
    Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tiziana Life Sciences PLC (“Tiziana” or “the Company”) – Notification of proposed admission to the Main Market and cancellation of trading on AIM

    author_avatar
    NASDAQ Market News

    Branded Generics Market is expected to witness a 7.3% CAGR and US$ 410 Bn by 2026

    Global Sales of Branded Generics Will Amass More Than US$ 400 Billion in Revenues ...

    author_avatar
    NASDAQ Market News

    LHC Group announces response and efforts to confront COVID-19 virus

    author_avatar
    NASDAQ Market News